34806605|t|Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
34806605|a|BACKGROUND: Cognitive deficit is mainly clinical characteristic of Alzheimer's disease (AD). Recent reports showed adiponectin and its analogues could reverse cognitive impairments, lower amyloid-beta protein (Abeta) deposition, and exert anti-inflammatory effects in different APP/PS1 AD model mice mainly exhibiting amyloid plaque pathology. However, the potential in vivo electrophysiological mechanism of adiponectin protecting against cognitive deficits in AD and the neuroprotective effects of adiponectin on 3xTg-AD mice including both plaque and tangle pathology are still unclear. OBJECTIVE: To observe the effects of adiponectin treatment on cognitive deficits in 3xTg-AD mice, investigate its potential in vivo electrophysiological mechanism, and testify its anti-inflammatory effects. METHODS: Barnes maze test, Morris water maze test, and fear conditioning test were used to evaluate the memory-ameliorating effects of adiponectin on 3xTg-AD mice. In vivo hippocampal electrophysiological recording was used to observe the change of basic synaptic transmission, long-term potentiation, and long-term depression. Immunohistochemistry staining and western blot were used to observe the activation of microglia and astroglia, and the expression levels of proinflammatory factors and anti-inflammtory factor IL-10. RESULTS: Adiponectin treatment could alleviate spatial memory and conditioned fear memory deficits observed in 3xTg-AD mice, improve in vivo LTP depression and LTD facilitation, inhibit overactivation of microglia and astroglia, decrease the expression of proinflammatory factors NF- kappaB and IL-1beta, and increase the expression level of IL-10 in the hippocampus of 3xTg-AD mice. CONCLUSION: Adiponectin could ameliorate cognitive deficits in 3xTg-AD mice through improving in vivo synaptic plasticity impairments and alleviating neuroinflammation in the hippocampus of 3xTg-AD mice.
34806605	0	11	Adiponectin	Gene	11450
34806605	56	87	Synaptic Plasticity Impairments	Disease	MESH:D010411
34806605	91	98	3xTg-AD	CellLine	CVCL:RN76
34806605	99	103	Mice	Species	10090
34806605	117	134	Cognitive deficit	Disease	MESH:D003072
34806605	172	191	Alzheimer's disease	Disease	MESH:D000544
34806605	193	195	AD	Disease	MESH:D000544
34806605	220	231	adiponectin	Gene	11450
34806605	264	285	cognitive impairments	Disease	MESH:D003072
34806605	315	320	Abeta	Gene	11820
34806605	349	361	inflammatory	Disease	MESH:D007249
34806605	387	390	PS1	Gene	19164
34806605	391	393	AD	Disease	MESH:D000544
34806605	400	404	mice	Species	10090
34806605	423	437	amyloid plaque	Disease	MESH:D058225
34806605	514	525	adiponectin	Gene	11450
34806605	545	563	cognitive deficits	Disease	MESH:D003072
34806605	567	569	AD	Disease	MESH:D000544
34806605	605	616	adiponectin	Gene	11450
34806605	620	627	3xTg-AD	CellLine	CVCL:RN76
34806605	628	632	mice	Species	10090
34806605	732	743	adiponectin	Gene	11450
34806605	757	775	cognitive deficits	Disease	MESH:D003072
34806605	779	786	3xTg-AD	CellLine	CVCL:RN76
34806605	787	791	mice	Species	10090
34806605	880	892	inflammatory	Disease	MESH:D007249
34806605	1037	1048	adiponectin	Gene	11450
34806605	1052	1059	3xTg-AD	CellLine	CVCL:RN76
34806605	1060	1064	mice	Species	10090
34806605	1218	1228	depression	Disease	MESH:D003866
34806605	1422	1427	IL-10	Gene	16153
34806605	1438	1449	Adiponectin	Gene	11450
34806605	1495	1527	conditioned fear memory deficits	Disease	MESH:D008569
34806605	1540	1547	3xTg-AD	CellLine	CVCL:RN76
34806605	1548	1552	mice	Species	10090
34806605	1574	1584	depression	Disease	MESH:D003866
34806605	1709	1719	NF- kappaB	Gene	18033
34806605	1724	1732	IL-1beta	Gene	16176
34806605	1771	1776	IL-10	Gene	16153
34806605	1799	1806	3xTg-AD	CellLine	CVCL:RN76
34806605	1807	1811	mice	Species	10090
34806605	1825	1836	Adiponectin	Gene	11450
34806605	1854	1872	cognitive deficits	Disease	MESH:D003072
34806605	1876	1883	3xTg-AD	CellLine	CVCL:RN76
34806605	1884	1888	mice	Species	10090
34806605	1915	1946	synaptic plasticity impairments	Disease	MESH:D010411
34806605	1963	1980	neuroinflammation	Disease	MESH:D000090862
34806605	2003	2010	3xTg-AD	CellLine	CVCL:RN76
34806605	2011	2015	mice	Species	10090
34806605	Positive_Correlation	MESH:D003866	11450
34806605	Negative_Correlation	MESH:D003072	11450
34806605	Negative_Correlation	11450	16176
34806605	Negative_Correlation	11450	11820
34806605	Negative_Correlation	MESH:D007249	11450
34806605	Association	MESH:D000544	11450
34806605	Negative_Correlation	11450	18033
34806605	Negative_Correlation	MESH:D000090862	11450
34806605	Positive_Correlation	11450	16153
34806605	Negative_Correlation	MESH:D010411	11450
34806605	Negative_Correlation	MESH:D008569	11450

